Your browser doesn't support javascript.
loading
Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options.
Alobaidi, Ahmed; Albadry, Ahmed; Murray, Anne.
Afiliação
  • Alobaidi A; Internal Medicine, Methodist Health System, Dallas, USA.
  • Albadry A; Faculty of Medicine, Charles University in Prague, Prague, CZE.
  • Murray A; Clinical Research Institute, Methodist Health System, Dallas, USA.
Cureus ; 15(9): e45750, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37872935
ABSTRACT
Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or non-severe (NSAA) based on the severity criteria. This classification system has implications for the prognosis and treatment options offered to patients. The prognosis of AA has improved over the past several decades with the advancements in supportive care, HSC transplant (HCT), and immunosuppressive therapy (IST). In this report, we present the case of a 26-year-old male diagnosed with VSAA after presenting with severe neutropenia and fever. The patient ultimately underwent HSC transplantation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article